Drug interactions
Donepezil transdermal + Ipratropium-salbutamol
Severity: Moderate
Donepezil transdermal and Ipratropium-salbutamol: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Donepezil increases cholinergic activity, whereas ipratropium blocks muscarinic receptors, so each can reduce the effect of the other. Donepezil may also cause bronchoconstriction or bradycardia, which is relevant in airway disease. Inhaled ipratropium has limited systemic exposure, so the effect is usually modest.
What this interaction means in plain words
Donepezil transdermal and Ipratropium-salbutamol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Pharmacodynamic antagonism between a cholinesterase inhibitor and a muscarinic antagonist.
What to do
Monitor respiratory symptoms and heart rate, and review bronchodilator effectiveness and cognitive response if either changes.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Donepezil transdermal and Ipratropium-salbutamol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Frequently asked questions
Can I take Donepezil transdermal with Ipratropium-salbutamol?
MediHelp rates the interaction as moderate. Donepezil transdermal and Ipratropium-salbutamol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Donepezil increases cholinergic activity, whereas ipratropium blocks muscarinic receptors, so each can reduce the effect of the other. Donepezil may also cause bronchoconstriction or bradycardia, which is relevant in airway disease. Inhaled ipratropium has limited systemic exposure, so the effect is usually modest.
How serious is the interaction between Donepezil transdermal and Ipratropium-salbutamol?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor respiratory symptoms and heart rate, and review bronchodilator effectiveness and cognitive response if either changes.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
